NCT00001007View on ClinicalTrials.gov

A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

Trial Locations (6)

21287

Johns Hopkins Hosp, Baltimore

35294

Univ of Alabama at Birmingham, Birmingham

94305

Stanford Univ School of Medicine, Stanford

212874933

Johns Hopkins Hosp - Pediatric, Baltimore

277103499

Duke Univ Med Ctr, Durham

02118

Boston Med Ctr, Boston

Sponsors

Collaborators (1)

Glaxo Wellcome
All Listed Sponsors
collaborator

Glaxo Wellcome

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001007 - A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth | Biotech Hunter | Biotech Hunter